ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients (DC-CIK)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01232062
Recruitment Status : Completed
First Posted : November 2, 2010
Last Update Posted : July 23, 2015
Sponsor:
Information provided by (Responsible Party):
Jun Ren, Beijing Cancer Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2011
  Actual Study Completion Date : October 2013